Alfacalcidol-supplemented raloxifene therapy has greater bone-sparing effect than raloxifene-alone therapy in postmenopausal Japanese women with osteoporosis or osteopenia

Increase in Bone Mass After Correction of Vitamin D Insufficiency in Bisphosphonate-Treated Patients

(2013) Jordan Geller et al.   Endocrine Practice

Vitamin D Insufficiency, Deficiency, and Bone Health

(2010) J. Chris Gallagher et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Update in Vitamin D

(2010) John S. Adams et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Assessment of adherence to treatment of postmenopausal osteoporosis with raloxifene and/or alfacalcidol in postmenopausal Japanese women

(2009) Itsuo Gorai et al.   JOURNAL OF BONE AND MINERAL METABOLISM

1α,25(OH)2Vitamin D3Induction of ATP Secretion in Osteoblasts

(2009) Payal Biswas et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Clinical Value of Monitoring BMD in Patients Treated With Bisphosphonates for Osteoporosis

(2009) Nelson B Watts et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Indirect Regulation of PTH by Estrogens May Require FGF23

(2009) N. Carrillo-Lopez et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Efficacy of Combined Treatment with Raloxifene and Alfacalcidol on Bone Density and Biochemical Markers of Bone Turnover in Postmenopausal Osteoporosis

(2008) Takafumi MAJIMA et al.   ENDOCRINE JOURNAL

Changes in 25-Hydroxyvitamin D3 to oral treatment with vitamin D3 in postmenopausal females with osteoporosis

(2008) H. C. Hoeck et al.   OSTEOPOROSIS INTERNATIONAL

Vitamin D insufficiency does not affect response of bone mineral density to alendronate

(2008) D. M. Antoniucci et al.   OSTEOPOROSIS INTERNATIONAL

Vitamin D status and response to treatment in post-menopausal osteoporosis

(2008) S. Adami et al.   OSTEOPOROSIS INTERNATIONAL

Global vitamin D levels in relation to age, gender, skin pigmentation and latitude: an ecologic meta-regression analysis

(2008) T. Hagenau et al.   OSTEOPOROSIS INTERNATIONAL